Digital PCR: Architecture, Analytical Performance, and Regulatory Framework for Precision Diagnostics

Main Article Content

Saket Mishra

Abstract

Digital polymerase chain reaction (dPCR) has become a groundbreaking technology for precise nucleic acid quantification, addressing the inherent limitations of traditional quantitative PCR by employing Poisson-statistics-based endpoint analysis of thousands of distinct reaction partitions. This review looks at the architecture, performance, and future of cloud-integrated microfluidic array platebased dPCR platforms, with a focus on the QuantStudio Absolute Q system. I systematically assess the engineering principles that form the foundation of Microfluidic Array Plate (MAP) technology, as well as the optical and thermal design of instruments and the complete analytical workflows, from sample preparation to cloud-based population-scale analytics. A critical evaluation of the regulatory frameworks, including FDA 510(k), Emergency Use Authorization, and IVDD/IVDR, is conducted alongside software quality assurance standards in accordance with IEC62304 and ISO14971. Robotic process automation and agile development paradigms are examined as facilitators of expedited, compliant release cycles. Qualitative comparisons are made between competing dPCR modalities for liquid biopsy, copy number variation, viral load monitoring, and gene editing validation applications to see which ones work better. The combination of microfluidic precision, multi-channel optics, AWSnative data lake infrastructure, and full risk management shows that array-based dPCR is the basic building block for precision medicine on a large scale. The remaining limitations and future directions, such as point-of-care miniaturization, and enhanced multiplexing, are examined.

Article Details

Section
Articles